MarketPeel
Insider Trading Intelligence
DL

David Aaron Lehman

LUNG
GENERAL COUNSEL · PULMONX CORP · CIK 0001354228
FILING MIX · LIFETIME16%/84%
BUYS
12
SELLS
61
TOTAL VALUE
$644.7K
COMPANIES
1
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
376,161
AVG SELL PX
$5.47
TRADE KIND
SHOWING 73 / 73
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
54 backtested trades · 8 horizons · 46 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by David Aaron Lehman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d54+38.89%+3.81%-0.06%+3.87%+3.12%2.98
14d54+57.41%+2.46%+0.31%+2.15%-3.18%0.99
30d54+66.67%-1.87%+0.53%-2.40%-5.21%-1.48
60d54+75.93%-12.42%+2.11%-14.53%-8.61%-5.24
90d54+50.00%-13.46%+4.34%-19.53%-14.25%-4.97
180d54(4 pending)+92.00%-26.33%+8.52%-36.74%-29.34%-8.49
1y54(12 pending)+100.00%-50.41%+17.93%-68.50%-68.29%-18.40
2y54(30 pending)+100.00%-71.06%+41.21%-111.09%-115.55%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LUNG · 376,161 shares · as of Jun 1, 2026
097,689195,378293,066390,75520222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 12 buys / 61 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
3,876$1.54$6.0K386,879Jun 1, 2026Jun 3, 2026View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
2,264$1.54$3.5K384,615Jun 1, 2026Jun 3, 2026View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
3,539$1.54$5.5K381,076Jun 1, 2026Jun 3, 2026View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
4,915$1.54$7.6K376,161Jun 1, 2026Jun 3, 2026View →
LUNG
PULMONX CORP
PURCHASEGRANT
Stock grant
150,000390,755Mar 2, 2026Mar 4, 2026View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
4,433$1.43$6.3K247,396Mar 2, 2026Mar 4, 2026View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
2,590$1.43$3.7K244,806Mar 2, 2026Mar 4, 2026View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
1,163$1.43$1.7K251,829Mar 2, 2026Mar 4, 2026View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
4,051$1.43$5.8K240,755Mar 2, 2026Mar 4, 2026View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
3,725$1.57$5.8K258,569Dec 1, 2025Dec 2, 2025View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
3,401$1.57$5.3K252,992Dec 1, 2025Dec 2, 2025View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
2,176$1.57$3.4K256,393Dec 1, 2025Dec 2, 2025View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
976$1.57$1.5K262,294Dec 1, 2025Dec 2, 2025View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
3,541$1.60$5.7K268,569Sep 2, 2025Sep 3, 2025View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
929$1.60$1.5K272,110Sep 2, 2025Sep 3, 2025View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
2,068$1.60$3.3K266,501Sep 2, 2025Sep 3, 2025View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
3,231$1.60$5.2K263,270Sep 2, 2025Sep 3, 2025View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
2,099$3.13$6.6K276,322Jun 2, 2025Jun 4, 2025View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
943$3.13$3.0K282,018Jun 2, 2025Jun 4, 2025View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
535$3.14$1.7K282,961Jun 2, 2025Jun 4, 2025View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
3,597$3.13$11.3K278,421Jun 2, 2025Jun 4, 2025View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
3,283$3.13$10.3K273,039Jun 2, 2025Jun 4, 2025View →
LUNG
PULMONX CORP
PURCHASEGRANT
Stock grant
108,000283,496Mar 3, 2025Mar 5, 2025View →
LUNG
PULMONX CORP
SALE10b5-1
10b5-1 plan
4,490$7.14$32.1K191,515Mar 3, 2025Mar 5, 2025View →
LUNG
PULMONX CORP
SALE10b5-1
10b5-1 plan
13,622$7.97$108.6K175,496Mar 3, 2025Mar 5, 2025View →
LUNG
PULMONX CORP
SALE10b5-1
10b5-1 plan
1,177$7.14$8.4K196,005Mar 3, 2025Mar 5, 2025View →
LUNG
PULMONX CORP
SALE10b5-1
10b5-1 plan
2,397$7.14$17.1K189,118Mar 3, 2025Mar 5, 2025View →
LUNG
PULMONX CORP
SALE10b5-1
10b5-1 plan
669$7.14$4.8K197,182Mar 3, 2025Mar 5, 2025View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
410$6.18$2.5K202,938Dec 2, 2024Dec 4, 2024View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
2,755$6.19$17.1K199,461Dec 2, 2024Dec 4, 2024View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
722$6.19$4.5K202,216Dec 2, 2024Dec 4, 2024View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
1,610$6.18$9.9K197,851Dec 2, 2024Dec 4, 2024View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
758$6.69$5.1K207,926Sep 3, 2024Sep 5, 2024View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
2,890$6.69$19.3K205,036Sep 3, 2024Sep 5, 2024View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
429$6.71$2.9K208,684Sep 3, 2024Sep 5, 2024View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
1,688$6.69$11.3K203,348Sep 3, 2024Sep 5, 2024View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
409$6.97$2.9K214,179Jun 3, 2024Jun 5, 2024View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
719$6.97$5.0K213,460Jun 3, 2024Jun 5, 2024View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
1,603$6.97$11.2K209,113Jun 3, 2024Jun 5, 2024View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
2,744$6.97$19.1K210,716Jun 3, 2024Jun 5, 2024View →
LUNG
PULMONX CORP
PURCHASEGRANT
Stock grant
34,500179,988Mar 1, 2024Mar 5, 2024View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
809$9.06$7.3K148,571Mar 1, 2024Mar 5, 2024View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
3,083$9.06$27.9K145,488Mar 1, 2024Mar 5, 2024View →
LUNG
PULMONX CORP
SALE
GENERAL COUNSEL
459$9.06$4.2K149,380Mar 1, 2024Mar 5, 2024View →
LUNG
PULMONX CORP
PURCHASEGRANT
Stock grant
69,10069,100Mar 1, 2024Mar 5, 2024View →
LUNG
PULMONX CORP
PURCHASEGRANT
Stock grant
34,50034,500Mar 1, 2024Mar 7, 2024View →
LUNG
PULMONX CORP
PURCHASEGRANT
Stock grant
69,100214,588Mar 1, 2024Mar 7, 2024View →
LUNG
PULMONX CORP
SALE
General Counsel
2,700$10.34$27.9K149,839Dec 1, 2023Dec 5, 2023View →
LUNG
PULMONX CORP
SALE
General Counsel
402$10.33$4.2K153,246Dec 1, 2023Dec 5, 2023View →
LUNG
PULMONX CORP
SALE
General Counsel
707$10.34$7.3K152,539Dec 1, 2023Dec 5, 2023View →
LUNG
PULMONX CORP
SALE
General Counsel
701$10.01$7.0K156,321Sep 1, 2023Sep 6, 2023View →
LUNG
PULMONX CORP
SALE
General Counsel
398$10.01$4.0K157,022Sep 1, 2023Sep 6, 2023View →
LUNG
PULMONX CORP
SALE
General Counsel
2,673$10.01$26.8K153,648Sep 1, 2023Sep 6, 2023View →
LUNG
PULMONX CORP
SALE
General Counsel
399$11.48$4.6K160,797Jun 1, 2023Jun 2, 2023View →
LUNG
PULMONX CORP
SALE
General Counsel
701$11.48$8.0K160,096Jun 1, 2023Jun 2, 2023View →
LUNG
PULMONX CORP
SALE
General Counsel
2,676$11.48$30.7K157,420Jun 1, 2023Jun 2, 2023View →
LUNG
PULMONX CORP
PURCHASEGRANT
Stock grant
118,300161,196Mar 1, 2023Mar 3, 2023View →
LUNG
PULMONX CORP
SALE
General Counsel
806$11.03$8.9K42,896Mar 1, 2023Mar 3, 2023View →
LUNG
PULMONX CORP
PURCHASEGRANT
Stock grant
81,00081,000Mar 1, 2023Mar 3, 2023View →
LUNG
PULMONX CORP
SALE
General Counsel
458$11.03$5.1K43,702Mar 1, 2023Mar 3, 2023View →
LUNG
PULMONX CORP
SALE
General Counsel
682$5.93$4.0K44,160Dec 1, 2022Dec 5, 2022View →
LUNG
PULMONX CORP
SALE
General Counsel
387$5.93$2.3K44,842Dec 1, 2022Dec 5, 2022View →
LUNG
PULMONX CORP
SALE
General Counsel
690$17.88$12.3K45,229Sep 1, 2022Sep 6, 2022View →
LUNG
PULMONX CORP
SALE
General Counsel
392$17.89$7.0K45,919Sep 1, 2022Sep 6, 2022View →
LUNG
PULMONX CORP
SALE
General Counsel
386$18.05$7.0K46,990Jun 1, 2022Jun 3, 2022View →
LUNG
PULMONX CORP
SALE
General Counsel
679$18.05$12.3K46,311Jun 1, 2022Jun 3, 2022View →
LUNG
PULMONX CORP
SALE
General Counsel
458$25.91$11.9K16,376Mar 1, 2022Mar 3, 2022View →
LUNG
PULMONX CORP
PURCHASEGRANT
Stock grant
31,00047,376Mar 1, 2022Mar 3, 2022View →
LUNG
PULMONX CORP
PURCHASEGRANT
Stock grant
68,70068,700Mar 1, 2022Mar 3, 2022View →
LUNG
PULMONX CORP
SALE
General Counsel
383$32.73$12.5K16,834Dec 1, 2021Dec 3, 2021View →
LUNG
PULMONX CORP
SALE
General Counsel
383$40.09$15.4K17,217Sep 1, 2021Sep 3, 2021View →
LUNG
PULMONX CORP
PURCHASEGRANT
Stock grant
39,90039,900Jun 1, 2021Jun 11, 2021View →
LUNG
PULMONX CORP
PURCHASEGRANT
Stock grant
17,60017,600Jun 1, 2021Jun 11, 2021View →
Other insiders · LUNG
Loading peer insiders…
About this filer
CIK 0001354228
ROLE
General Counsel
PRIMARY
LUNG
COMPANIES
1
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001354228DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback